This study investigates pro-social and pro-environmental preferences through a survey experiment that examines behavioral shifts from single-use medical masks to reusable fabric masks among healthy individuals. Drawing on goal-framing theory, we evaluate the impact of the WHO’s recommendation alongside two additional informational interventions encouraging the use of fabric masks over medical-grade alternatives. Using an add-on experimental design, participants were randomly assigned to one of three treatment groups, with baseline responses serving as a reference group.

Abstract

Sustainable intensification of livestock production relies critically on effective disease management, yet the environmental implications of current practices remain poorly understood. The study was designed to evaluate the efficacy of acaricide use in tick control in Kenya’s dairy sector affects environmental and human health risks. Using original survey data from dairy farmers and a two-stage least square (2SLS) approach, the results found that farmers’ adaptation to perceived ineffective tick treatment leads to potentially harmful practices.

Abstract

Abstract

Introduction: South Sudan has higher rates of under-five morbidity and mortality compared to other countries in the African region. Diarrhea is one of the major causes of death among children under five, both globally and in South Sudan. One of the main factors contributing to diarrheal infections, especially among young children, is the source of drinking water. This paper aims to establish the effect of drinking water sources on diarrheal morbidities among children under five in South Sudan.

Abstract

Abstract

Background

Kenya faces a significant mental health crisis, with 1.9 million reported cases of depression and 10.6% prevalence of post-traumatic stress disorder (PTSD). The economic burden of mental health conditions was 62.2 billion Kenyan shillings in 2021, accounting for 0.6% of GDP. This study performed a cost-benefit analysis (CBA) of Interpersonal Psychotherapy (IPT) and fluoxetine (FLX) for treating depression and PTSD in a primary care setting.

Abstract

Mental health disorders (MHD) rank among the top 10 global causes of disease burden, with significant economic and social costs. Current treatments often have limited efficacy or tolerability, and there has been little recent innovation in treatments. In the past decade, clinical research on Psychedelic-Assisted Therapies (PAT) for treating MHD has increased in high-income countries, while most MHD burdens are in low and middle-income countries. This study assesses the readiness of implementing PAT in 136 low- and middle-income countries.

Abstract

Background